Insmed
INSM
#802
Rank
$30.04 B
Marketcap
$139.40
Share price
-3.09%
Change (1 day)
89.15%
Change (1 year)

Insmed (INSM) - P/B ratio

P/B ratio as of March 2026 : 31.8

According to Insmed's latest financial reports the company has a price-to-book ratio of 67.218.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Insmed - P/B ratio (from 2001 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-3139.9-8.45%
2024-12-3143.6-426.71%
2023-12-31-13.4-143.4%
2022-12-3130.8291.78%
2021-12-317.86-36.09%
2020-12-3112.350.19%
2019-12-318.1868.05%
2018-12-314.87-26.37%
2017-12-316.6124.81%
2016-12-315.3047.23%
2015-12-313.60-13%
2014-12-314.14-10.88%
2013-12-314.64166.39%
2012-12-311.74208.92%
2011-12-310.564110.17%
2010-12-310.5120-36.72%
2009-12-310.8091-103.99%
2008-12-31-20.3-331.38%
2007-12-318.7536.27%
2006-12-316.42-48.39%
2005-12-3112.4-8.78%
2004-12-3113.6213.74%
2003-12-314.35584.38%
2002-12-310.6355

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Novartis
NVS
6.47-79.64%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
8.45-73.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
7.22-77.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
1.40-95.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
2.66-91.63%๐Ÿ‡บ๐Ÿ‡ธ USA